You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PRO 140

Showing 1 - 25 of 3,271
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection Trial in San Francisco (PRO 140 350, PRO 140 525, PRO 140 700)

Active, not recruiting
  • HIV-1-infection
  • PRO 140 350
  • +2 more
  • San Francisco, California
    Quest Clinical Research
Mar 4, 2022

Triple Negative Breast Tumors Trial in San Francisco, Chicago (350 mg leronlimab, 525 mg leronlimab, 700 mg leronlimab)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • 350 mg leronlimab
  • +4 more
  • San Francisco, California
  • +1 more
Mar 18, 2022

Solid Tumor, Adult Trial in San Francisco (Leronlimab)

Active, not recruiting
  • Solid Tumor, Adult
  • San Francisco, California
    Quest Clinical Research
Jun 30, 2022

Metastatic Triple-Negative Breast Carcinoma Trial (Leronlimab)

No longer available
  • Metastatic Triple-Negative Breast Carcinoma
  • (no location specified)
Jan 13, 2022

HIV, Human Immunodeficiency Virus Trial in San Francisco (PRO 140 350mg weekly SQ injection.)

Active, not recruiting
  • HIV
  • Human Immunodeficiency Virus
  • PRO 140 350mg weekly SQ injection.
  • San Francisco, California
    CD01-Extension Investigational Site
Sep 28, 2021

Hiv, Human Immunodeficiency Virus Trial (PRO 140 SC injections)

Active, not recruiting
  • Hiv
  • Human Immunodeficiency Virus
  • PRO 140 SC injections
  • (no location specified)
Sep 28, 2021

HIV Trial in United States (PRO 140 (350 mg), PRO 140 (525 mg), PRO 140 (700 mg))

Active, not recruiting
  • HIV
  • PRO 140 (350 mg)
  • +2 more
  • La Mesa, California
  • +11 more
Jan 13, 2022

CCR5, Microsatellite Stable, Metastatic Trial (700mg leronlimab weekly dose, 80mg Regorafenib at week 1, 120mg Regorafenib at

Withdrawn
  • CCR5
  • +3 more
  • 700mg leronlimab weekly dose
  • +3 more
  • (no location specified)
Feb 15, 2023

HIV, Human Immunodeficiency Virus Trial in San Francisco (PRO 140 350mg weekly SQ injection.)

Completed
  • HIV
  • Human Immunodeficiency Virus
  • PRO 140 350mg weekly SQ injection.
  • San Francisco, California
    Quest Clinical Research
Sep 28, 2021

Graft Vs Host Disease Trial in United States (PRO 140)

Terminated
  • Graft Vs Host Disease
  • PRO 140
  • Miami, Florida
  • +7 more
Jan 13, 2022

Coronavirus Disease 2019 Trial in United States (Placebos, Leronlimab (700mg))

Completed
Has Results
  • Coronavirus Disease 2019
  • Placebo
  • Leronlimab (700mg)
  • Los Angeles, California
  • +11 more
Dec 8, 2022

HIV Trial in Puerto Rico, United States (PRO 140, Placebo, Optimized Background Regimen)

Completed
  • HIV
  • PRO 140
  • +2 more
  • Fountain Valley, California
  • +36 more
Sep 28, 2021

Coronavirus Disease 2019 Trial in United States (Placebos, Leronlimab (700mg))

Active, not recruiting
  • Coronavirus Disease 2019
  • Placebos
  • Leronlimab (700mg)
  • Alexander City, Alabama
  • +17 more
Jan 13, 2022

COVID-19 Pneumonia Trial in Brazil (Leronlimab, Placebo)

Suspended
  • COVID-19 Pneumonia
  • Ipiaú, BA, Brazil
  • +22 more
Apr 8, 2022

COVID-19 Pneumonia Trial in Brazil (Leronlimab, Placebo)

Suspended
  • COVID-19 Pneumonia
  • Ipiaú, BA, Brazil
  • +26 more
Apr 8, 2022

Diabetic Peripheral Neuropathy Trial in Worldwide (LY3556050, Placebo)

Not yet recruiting
  • Diabetic Peripheral Neuropathy
  • Mesa, Arizona
  • +54 more
Oct 3, 2023

Acute Diarrhoea Trial in Worldwide (Smecta, Smecta )

Completed
Has Results
  • Acute Diarrhoea
  • Algiers, Algeria
  • +70 more
Nov 4, 2020

Coronavirus Disease 2019 Trial in Aventura, Gainesville (Placebos, Leronlimab (700mg))

Completed
  • Coronavirus Disease 2019
  • Placebos
  • Leronlimab (700mg)
  • Aventura, Florida
  • +1 more
Jul 30, 2021

MCI, Mild Dementia Trial (Gentle Moves)

Not yet recruiting
  • MCI
  • Mild Dementia
  • Gentle Moves
  • (no location specified)
Mar 14, 2023

Healthy Trial in Zürich (Psilocybin, 3,4 Methylenedioxymethamphetamine, Methylphenidate)

Recruiting
  • Healthy
  • Zürich, Switzerland
    Psychiatrische Universitätsklinik Zürich
Oct 3, 2023

Diabetes, Type 2 Trial in United States (Blinded CGM, real-time CGM)

Recruiting
  • Diabetes Mellitus, Type 2
  • Blinded CGM
  • real-time CGM
  • Aurora, Colorado
  • +5 more
Nov 23, 2022

Type 2 Diabetes, Renal Impairment Trial in Worldwide (Insulin glargine 300 U/mL, Insulin degludec 100 U/mL)

Recruiting
  • Type 2 Diabetes Mellitus
  • Renal Impairment
  • Insulin glargine 300 U/mL
  • Insulin degludec 100 U/mL
  • Yuma, Arizona
  • +62 more
Dec 14, 2022

Arterial Hypertension and Hypervolemia Defined by

Recruiting
  • Kidney Transplant Patients
  • Measurement of systolic and diastolic blood pressure, impedancemetry, weight, creatinemia and Pro-BNP measurements
  • Nantes, Loire-Atlantique, France
    Nantes University Hospital
Nov 19, 2021

Hypertension Trial in Chicago (Hypertension Coaching Application and Home Monitor, Control: Tracking Application and Home

Completed
Has Results
  • Hypertension
  • Hypertension Coaching Application and Home Monitor
  • Control: Tracking Application and Home Monitor
  • Chicago, Illinois
    Northwestern Medical Group
Apr 14, 2022

Panthera D-SAD® Mandibular Advancement Orthosis in Sleep Apnea

Recruiting
  • Sleep Apnea, Obstructive
  • D-SAD
  • Angers, France
  • +1 more
Jul 13, 2022